Stroke RSS Page 5

Filtered By:
Specialty: Cardiology
Condition: Heart Failure

This page shows you your search results in order of relevance. This is page number 5.

Order by Relevance | Date

Total 4537 results found since Jan 2013.

Noninvasive Monitoring of Stroke Volume With Resynchronization Devices in Patients With Ischemic Cardiomyopathy
Conclusions: In CRT patients with chronic infarction and wall motion abnormalities, impedance is a valid parameter to estimate stroke volume and to guide optimization of CRT timing.
Source: Journal of Cardiac Failure - August 1, 2013 Category: Cardiology Authors: Michael Kühne, Mario Bocchiardo, Herbert Nägele, Beat Schaer, Michael Lippert, Christian Sticherling, Stefan Osswald Tags: Clinical Investigations Source Type: research

Anticoagulation and antiplatelet therapy for stroke prevention in atrial fibrillation patients in clinical practice of district hospital in Poland.
CONCLUSIONS: (1). Despite of high stroke risk determined by both scales only 39% of patients received OAC. (2). In the analyzed material the independent predictive factor in this group for prescribing OAC at discharge was arterial hypertension (in accordance with recommendations) and: the younger patients age, no history of stroke/TIA and other than paroxysmal type of AF. (3). Practice of the usage of OAC and/or antiplatelet therapy in AF patients discharged from Polish district hospital was in concordance with current guidelines of ESC neither in 2006 nor 2010. PMID: 23990227 [PubMed - as supplied by publisher]
Source: Polish Heart Journal - August 30, 2013 Category: Cardiology Authors: Bednarski J, Cieszewska E, Strzelecki A, Filipiak KJ Tags: Kardiol Pol Source Type: research

Change in Systolic Blood Pressure During Stroke, Functional Status, and Long-Term Mortality in an Elderly Population.
CONCLUSION: There is no evidence of association between change in SBP during the first week of stroke and short-term functional status and long-term mortality in this group of stroke patients. PMID: 26208674 [PubMed - as supplied by publisher]
Source: American Journal of Hypertension - July 24, 2015 Category: Cardiology Authors: Weiss A, Beloosesky Y, Kenett RS, Grossman E Tags: Am J Hypertens Source Type: research

Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea.
CONCLUSIONS: A high portion of AF/AFL patients with CHADS2 score ≥2 were undertreated with warfarin. As ischemic stroke is one of the leading causes of death in Korea, a more aggressive approach to prevent stroke in patients with AF/AFL is required. PMID: 26242197 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - August 1, 2015 Category: Cardiology Authors: Lee IH, Kim H, Je NK Tags: J Cardiol Source Type: research

Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
CONCLUSIONS: -The risk of stroke was only modestly higher in patients undergoing hemodialysis with new-onset AF than in those without AF, and it became insignificant when accounting for the competing risk of in-hospital death. PMID: 26680239 [PubMed - as supplied by publisher]
Source: Circulation - December 17, 2015 Category: Cardiology Authors: Shih CJ, Ou SM, Chao PW, Kuo SC, Lee YJ, Yang CY, Tarng DC, Lin CC, Huang PH, Li SY, Chen YT Tags: Circulation Source Type: research

Atrial fibrillation detected by continuous ECG monitoring using implantable loop recorder to prevent stroke in individuals at risk (The LOOP study): Rationale and design of a large randomized controlled trial
Conclusion The LOOP study will evaluate health benefits and cost-effectiveness of ILR as a screening tool for AF to prevent stroke in patients at risk. Secondary objectives include identification of risk factors for the development of AF and characterization of arrhythmias in the population. The trial holds the potential to influence the future of stroke prevention.
Source: American Heart Journal - February 20, 2017 Category: Cardiology Source Type: research

Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial
Conclusion The LOOP study will evaluate health benefits and cost-effectiveness of ILR as a screening tool for AF to prevent stroke in patients at risk. Secondary objectives include identification of risk factors for the development of AF and characterization of arrhythmias in the population. The trial holds the potential to influence the future of stroke prevention.
Source: American Heart Journal - March 14, 2017 Category: Cardiology Source Type: research

Factors associated with non –vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Conclusions In contemporary clinical practice, up to three-fourths of patients with new-onset AF are now initially treated with a NOAC for stroke prevention. Those selected for NOAC treatment had lower stroke and bleeding risk profiles, were more likely treated by cardiologists, and had higher socioeconomic status. Trial registration clinicaltrials.gov Identifier: NCT01701817
Source: American Heart Journal - April 25, 2017 Category: Cardiology Source Type: research

XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America
ConclusionsXANTUS-EL confirmed low stroke and major bleeding rates in patients with NVAF from EEMEA and Latin America. The population was younger but with more heart failure and hypertension than XANTUS; stroke/SE rate was similar but major bleeding lower.
Source: The Egyptian Heart Journal - October 5, 2018 Category: Cardiology Source Type: research

Cardio-Ankle Vascular Index Predicts Post-Discharge Stroke in Patients with Heart Failure.
CONCLUSION: CAVI independently predicts stroke in patients with HF.The trial registration number: UMIN000029132. PMID: 32981919 [PubMed - as supplied by publisher]
Source: Journal of Atherosclerosis and Thrombosis - September 29, 2020 Category: Cardiology Tags: J Atheroscler Thromb Source Type: research

Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
ConclusionsThe stroke/SE risk was the highest in the HFpEF group and comparable between the HFmrEF and HFrEF groups.
Source: ESC Heart Failure - February 26, 2021 Category: Cardiology Authors: Jae ‐Sun Uhm, Jun Kim, Hee Tae Yu, Tae‐Hoon Kim, So‐Ryoung Lee, Myung‐Jin Cha, Eue‐Keun Choi, Jung Myung Lee, Jin‐Bae Kim, Junbeom Park, Jin‐Kyu Park, Ki‐Woon Kang, Jaemin Shim, Hyung Wook Park, Young Soo Lee, Chang‐Soo Ki Tags: Original Research Article Source Type: research

Plasma D ‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial
ConclusionsIn COMMANDER-HF, rivaroxaban reduced the risk of stroke but the benefit may be confined to patients with D-dimer concentrations above 515 ng/mL. Prospective trials are warranted to confirm these findings.
Source: European Journal of Heart Failure - June 18, 2021 Category: Cardiology Authors: Jo ão Pedro Ferreira, Carolyn S.P. Lam, Stefan D. Anker, Mandeep R. Mehra, Dirk J. Veldhuisen, William M. Byra, David A. La Police, John G.F. Cleland, Barry Greenberg, Faiez Zannad Tags: Research article Source Type: research

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
AbstractImpaired left-ventricular ejection-fraction (LV-EF) is a known risk factor for ischemic stroke and systemic embolism in patients with heart failure (HF) even in the absence of atrial fibrillation. While stroke risk is inversely correlated with LV-EF in HF patients with sinus rhythm, strategies using anticoagulation with Vitamin-K antagonists (VKA) were futile as the increase in major bleedings outweighed the potential benefit in stroke reduction. Non-Vitamin K oral anticoagulants (NOACs) proved to be an effective and in general safer approach for stroke prevention in patients with atrial fibrillation and may also h...
Source: Clinical Research in Cardiology - August 27, 2021 Category: Cardiology Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20